Revised SPC: Targinact (oxycodone/naloxone) prolonged-release tablets

SPC now advises that caution is required when using Targinact for restless legs syndrome in patients with additional sleep apnoea syndrome due to the additive risk of respiratory depression.

Source:

electronic Medicines compendium